Technology

VIEW ALL TECHNOLOGY

Reportum Platform

Reportum is a unified adverse event platform managing both digital and analogue reports.

HaloPV Platform

Our revolutionary platform manages all multivigilance processes.

Vigilance Workbench Platform

The Vigilance Workbench, formerly known as Commonwealth Vigilance Workbench (CVW) signal detection platform.
Services
VIEW ALL SERVICES

Local Pharmacovigilance

Medical Device Vigilance

Healthcare Analytics Group

Medical Information Call Center

GRIP (Global Regulatory Intelligence Platform)
Case Management

ICSR Management

Literature Screening and Review

Data Migration

Medical Review of ICSRs

Submissions

Clinical Safety Management

SAE and SUSAR Management

Drug Safety and Reporting Training

Safety Management Plan
Signal & Risk Management

Signal Detection and Management

Benefit Risk Management

Drug Safety Physician Services

Regulatory Responses

Medical Writing

Aggregate Reports

Protocol Review

Risk Management Reports
Quality & Compliance

PV Audit-as-a-Service

QPPV Services

Eudravigilance Setup and Maintenance

PSMF Setup and Maintenance

Pharmacovigilance Consulting

PV Management Consulting

Pharmacovigilance Benchmarking

Regulatory Intelligence

Pharmacovigilance Training
Quantitative Signal Detection as a Service (QSDaaS)

Turn pharmacovigilance data into actionable insights with proven statistical methods and expert-guided signal detection.
Solutions

VIEW ALL SOLUTIONS

End-to-End Case Management

Qinecsa is a leading global provider of end-to-end pharmacovigilance solutions.

Next Generation Literature Management

Our cutting-edge literature screening system combines expert collaboration and AI-driven software.
Resources

VIEW ALL RESOURCES

Articles

Read the latest news and press articles from Qinecsa and partners.

Fact Sheets

Explore a wealth of information in our factsheets library.

Case Studies

Uncover stories showcasing our impactful solutions in our case studies library.

Webinars

Watch as we share our knowledge and expertise through engaging webinars.
Company

OUR COMPANY

Leadership Team

On a mission to drive positive change in the Pharmacovigilance industry.

Operational Team

At Qinecsa we understand the impact of the important work we do.

Who We Are

Our foundation is built on over many years of heritage expertise.

News & Events

Read through our latest news, upcoming events, and press releases.

Careers

Join us to forge your career path in one of the world’s most rewarding industries.

Contact

Partner with us.
News

News & Events

News

Get to know our Chief Operating Officer, John Cogan

March 19, 2025

News

Join the webinar: “Digital-First Intake: The Future of Pharmacovigilance”

March 11, 2025

News

Join Qinecsa at DIA Europe 2025

February 18, 2025

News

Industry Outlook 2025 – Part 2: Shifting Political Landscapes

January 30, 2025

News

Industry Outlook 2025 – Part 1: Through the Lens of a Service Provider

January 29, 2025

News

Sign up for the latest Literature Screening webinar! Learn about AI automation and more…

January 10, 2025

News

Join Qinecsa at DIA 2025 Pharmacovigilance & Risk Management Strategies Conference

January 7, 2025

News

PharmaVoice’s Crystal Ball: The industry’s AI future

January 7, 2025

News

Trendspotting: Predictions for Clinical Research in 2025

January 7, 2025

News

Drug Solutions Podcast: Realizing AI’s Potential

December 20, 2024

News

High-profile CEO appointment signals major new growth phase for class-leading pharmacovigilance specialist Qinecsa

October 8, 2024

News

Qinecsa Announces World Drug Safety Congress Americas Sponsorship

August 30, 2024

News

Qinecsa Sponsors the World Drug Safety Congress Europe

August 22, 2024

Medical device and combination products

News

Qinecsa featured in International Pharmaceutical Industry (IPI) editorial

July 11, 2024

Qinecsa at the Insife Annual Convention 2024

Events

Join Qinecsa at the Insife Annual Convention 2024

July 8, 2024

News

Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024

June 13, 2024

Events

Join Qinecsa at DIA Global Annual Meeting 2024

May 14, 2024

News

Qinecsa releases on-demand webinar on mastering Medical Device regulations

April 22, 2024

News

Stanley Capital-backed portfolio company Qinecsa acquires Insife

March 21, 2024

Events

Join Qinecsa at DIA Europe 2024

February 8, 2024

Events

Join Qinecsa at Virtue Insights 34th Pharmacovigilance UK & EU 2024

January 9, 2024

Events

Join Qinecsa at DIA Global Pharmacovigilance and Risk Management Strategies Conference

January 5, 2024

News

Qinecsa appoints John Freeman JD, M.Sc., B.Sc. to the Board of Directors

December 14, 2023

News

Launching the next-generation Literature Management solution

December 13, 2023

Events

Join Qinecsa at J.P. Morgan Healthcare Conference 2024

December 6, 2023

News

Qinecsa appoints Arthur Shih as General Counsel

November 7, 2023

News

Introducing the Qinecsa PV Insights Network: Connecting peers for practical drug safety solutions

August 10, 2023

Events

Join Qinecsa at World Drug Safety Congress US, 18-19 October, Boston

July 20, 2023

Events

Join Qinecsa at World Drug Safety Congress Europe, 4-5 October, Amsterdam

July 10, 2023

Events

Join Qinecsa at 32nd Pharmacovigilance 2023, 26-27 April, Boston

April 19, 2023

Events

Join Qinecsa at 31st Pharmacovigilance 2023, 1-2 February, London

January 25, 2023

News

Stanley Capital-backed portfolio company Qinecsa acquires Commonwealth Informatics

December 15, 2022

Events

Join Qinecsa at 6th ISoP Seminar, Boston

November 22, 2022

Events

Join Qinecsa at WDSC Americas, 4-5 October 2022, Boston

September 14, 2022

Events

Join Qinecsa at WDSC EU, 27-29 September 2022, Amsterdam

September 12, 2022

News

Drug Safety and Pharmacovigilance Services Solutions (DSS) rebrand as Qinecsa Solutions

July 12, 2022

Join Our Newsletter.

Build Your Career with Qinecsa

At Qinecsa we understand the impact of the important work we do. We provide the right tools to empower our people and our passion towards drug safety makes us a unique group of talented people with common goal.